We primarily intend to focus on acquiring a growth-oriented business with an enterprise value between $150 million and $500 million.  Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region other than we have agreed that we will not undertake an initial business combination with any entity headquartered in or that […]

We intend to initially focus our search on businesses that participate in the global energy transition ecosystem and are facilitating the ways that energy is produced, stored, transmitted, distributed and consumed, all while reducing or mitigating greenhouse gas emissions. We will focus on companies that serve key and evolving segments in the clean energy ecosystem, […]

We are a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases worldwide. Our versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines. Our lead influenza (flu) vaccine program uses proprietary technology to identify specific epitopes, […]

(Note: Yoshiharu Global Co. upsized its IPO at pricing on Sept. 8, 2022, to 2.94 million shares, up from 2.45 million shares in the prospectus, and priced its IPO at $4.00, the low end of its $4.00-to-$5.00 range, to raise $11.76 million. In an S-1/A filing dated Sept. 2, 2022, Yoshiharu Global Co. cut its […]

We are the largest for-profit thrift operator in the United States and Canada based on number of stores. With over 22,000 team members, we operate a total of 317 stores under the Savers, Value Village, Village des Valeurs, Unique and 2nd Ave. banners. The U.S. secondhand market, which is a subset of the broader retail market, was estimated […]

It is our intention to pursue prospective targets that are based in the United States and /or Asia (excluding China) with a focus in the technology, media and telecom (TMT) sector. We shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau). We […]

We intend to focus our search on growth assets in Asia, including companies in the technology and consumer sectors. We shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau). (Incorporated in the Cayman Islands)

(Note: Solta Medical Corp. withdrew its IPO plans in an SEC filing dated Nov. 21, 2022. No terms had been set, but the IPO proceeds were estimated at up to $200 million. Solta Medical Corp. filed its S-1 on Feb. 8, 2022. The company’s parent, Bausch Health Companies Inc. (BHC) planned to spin off Solta […]

(Note: This is NOT an IPO. This is a NASDAQ uplisting  from the OTC market. This is a unit offering. Each Unit consists of one share of Common Stock, par value $0.001, which we refer to as the “Common Stock”, and one warrant (each a “Warrant”) to purchase one share of Common Stock. The price […]

We intend to focus our search in Latin America and in sectors where Patria has developed investment expertise (including but not limited to healthcare, food and beverage, logistics, agribusiness, education, and financial services). We will pursue an initial business combination with an established business with scale, attractive growth prospects, high-quality shareholders and management, and sustainable […]